Pediatric Myopia Progression Slowed by Low-Dose Atropine

TUESDAY, June 6, 2023 -- Low-dose atropine treatment reduces pediatric myopia progression compared with placebo over three years of treatment, according to a study published online June 1 in JAMA Ophthalmology. Karla Zadnik, O.D., Ph.D., from The...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news